weight loss drugs other than glp 1 GLP-1: Genetic Variants Related to GLP-1 RA Medications GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition

Seufert J, Gallwitz B

1 Safety The most common ADEs seen with GLP-1 RAs are nausea, vomiting, and diarrhea, to which patients can develop tolerance over time

Tirzepatide targets both GLP-1 and another incretin receptor called GIP

Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material

It arises from exenatides central appetite suppression and possibly from nausea reducing caloric intake